JP2016508501A - 赤血球を回復させるための方法 - Google Patents

赤血球を回復させるための方法 Download PDF

Info

Publication number
JP2016508501A
JP2016508501A JP2015556127A JP2015556127A JP2016508501A JP 2016508501 A JP2016508501 A JP 2016508501A JP 2015556127 A JP2015556127 A JP 2015556127A JP 2015556127 A JP2015556127 A JP 2015556127A JP 2016508501 A JP2016508501 A JP 2016508501A
Authority
JP
Japan
Prior art keywords
blood
composition
red blood
subject
blood cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015556127A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016508501A5 (enExample
Inventor
グレイ アラン
グレイ アラン
シー．ヒギンズ ジョエル
シー．ヒギンズ ジョエル
ディー．ランドリガン マシュー
ディー．ランドリガン マシュー
カニンガム グラント
カニンガム グラント
Original Assignee
バイオメット バイオロジクス，リミティド ライアビリティ カンパニー
バイオメット バイオロジクス，リミティド ライアビリティ カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/756,116 external-priority patent/US9102918B2/en
Application filed by バイオメット バイオロジクス，リミティド ライアビリティ カンパニー, バイオメット バイオロジクス，リミティド ライアビリティ カンパニー filed Critical バイオメット バイオロジクス，リミティド ライアビリティ カンパニー
Publication of JP2016508501A publication Critical patent/JP2016508501A/ja
Publication of JP2016508501A5 publication Critical patent/JP2016508501A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7019—Ischaemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
JP2015556127A 2013-01-31 2014-01-30 赤血球を回復させるための方法 Pending JP2016508501A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13/756,116 2013-01-31
US13/756,116 US9102918B2 (en) 2013-01-31 2013-01-31 Methods for rejuvenating red blood cells
US13/844,773 US9103842B2 (en) 2013-01-31 2013-03-15 Methods for rejuvenating red blood cells
US13/844,773 2013-03-15
PCT/US2014/013845 WO2014120919A1 (en) 2013-01-31 2014-01-30 Methods for rejuvenating red blood cells

Publications (2)

Publication Number Publication Date
JP2016508501A true JP2016508501A (ja) 2016-03-22
JP2016508501A5 JP2016508501A5 (enExample) 2017-03-16

Family

ID=50193576

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015556127A Pending JP2016508501A (ja) 2013-01-31 2014-01-30 赤血球を回復させるための方法

Country Status (4)

Country Link
US (2) US9103842B2 (enExample)
EP (1) EP2950802A1 (enExample)
JP (1) JP2016508501A (enExample)
WO (1) WO2014120919A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9808487B2 (en) 2013-01-31 2017-11-07 Biomet Biologics, Llc Methods for rejuvenating red blood cells
US9950012B2 (en) 2013-01-31 2018-04-24 Biomet Biologics, Llc Methods for rejuvenating red blood cells

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9066909B2 (en) 2012-09-06 2015-06-30 Biomet Biologics, Llc Methods for producing and using rejuvenated red blood cells
US10253295B2 (en) 2012-09-06 2019-04-09 Biomet Manufacturing, Llc Methods for producing rejuvenated red blood cells
US9011408B2 (en) 2013-01-31 2015-04-21 Biomet Biologics, Llc Functionally-closed, sterile blood processing solution system and method
EP3060269B1 (en) 2013-10-21 2019-07-10 Biomet Biologics, LLC Cell washing device using a wave
FR3069323B1 (fr) * 2017-07-20 2023-10-20 Lsee Bandelettes electrochimiques permettant le suivi de la degradation des graisses de l'organisme et leur procede de preparation
EP4096687A4 (en) * 2020-01-28 2024-02-28 Orgenesis Inc. Process and system for acellular therapy

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02152923A (ja) * 1988-09-27 1990-06-12 Res Dev Corp Of Japan 体外血液循環装置に使用する血液添加組成物
US20050233302A1 (en) * 2004-02-18 2005-10-20 Hess John R Compositions and methods for the storage of red blood cells
JP2005535279A (ja) * 2001-11-16 2005-11-24 ホリンガー・ディジタル・インコーポレイテッド 栄養サプリメンテーションによる冷蔵赤血球の有効貯蔵期間を延長するための方法
WO2011103179A1 (en) * 2010-02-16 2011-08-25 Viacell, Llc Arginine-containing compositions and methods for treating red blood cells

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3874384A (en) 1971-11-01 1975-04-01 American Hospital Supply Corp Improved blood storage unit and method of storing blood
US4004586A (en) 1975-03-12 1977-01-25 Baxter Travenol Laboratories, Inc. Method and apparatus for sealed, sterile connection
US4116646A (en) 1977-05-20 1978-09-26 Millipore Corporation Filter unit
JPS62501890A (ja) 1985-02-26 1987-07-30 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテッド 流体移換システム
US4994039A (en) 1985-11-15 1991-02-19 Mattson Philip D Apparatus and method for patients from a single donor or a restricted group of donors
US5098371A (en) 1987-10-24 1992-03-24 Kawasumi Laboratories, Inc. Switch bag type blood gathering set
CA2067134C (en) 1989-10-06 2001-02-13 Harold T. Meryman Procedure for storing red cells with prolonged maintenance of cellular concentrations of atp and 2,3 dpg
US20010037978A1 (en) 1999-04-20 2001-11-08 Daryl R. Calhoun Filter assembly having a flexible housing and method of making same
US7169547B2 (en) 1994-12-05 2007-01-30 New York Blood Center, Inc. High concentration white blood cells as a therapeutic product
US6190855B1 (en) 1996-10-28 2001-02-20 Baxter International Inc. Systems and methods for removing viral agents from blood
WO1998032840A1 (en) 1997-01-24 1998-07-30 Asahi Medical Co., Ltd. Method for separating cells
US6059968A (en) 1998-01-20 2000-05-09 Baxter International Inc. Systems for processing and storing placenta/umbilical cord blood
US6267745B1 (en) 1998-05-21 2001-07-31 Baxter International Inc. Confined air tube and methods for handling air in closed blood processing systems
US6358420B2 (en) 1998-06-01 2002-03-19 Baxter International Inc. Blood collection method employing an air venting blood sample tube
JP3517359B2 (ja) 1998-09-14 2004-04-12 テルモ株式会社 細胞分離・回収装置および細胞の分離・回収方法
AU6912500A (en) 1999-08-25 2001-03-19 Gmp Companies, Inc. Enhanced oxygen delivery in mammals, methods and reagents related thereto
JP2002173433A (ja) 2000-12-04 2002-06-21 Terumo Corp 白血球除去血液製剤の調製方法および血液セット
US20030124504A1 (en) 2001-11-16 2003-07-03 Bitensky Mark W. Additive solution for blood preservation
WO2004082741A1 (ja) 2003-03-20 2004-09-30 Terumo Kabushiki Kaisha 血液処理セットおよび細胞処理セット
US7569026B2 (en) 2003-10-02 2009-08-04 Terumo Kabushiki Kaisha Method of producing blood processing circuits and filter unit
US20050074743A1 (en) 2003-10-06 2005-04-07 Purmal Andrei A. Method and composition for treating a biological sample
US20110139276A1 (en) 2004-11-17 2011-06-16 Noble House Group Pty Ltd. Sterile sampling methods and apparatus
DE102004035352B4 (de) 2004-07-21 2007-05-10 Gerätezentrale für Bluttransfusion des Österreichischen Roten Kreuzes GmbH Geschlossenes steriles System zum Filtrieren von biologischen oder medizinischen Flüssigkeiten, insbesondere von Vollblut
WO2006016421A1 (ja) 2004-08-12 2006-02-16 Jms Co., Ltd. 濾過装置及び濾過方法
CA2617175A1 (en) 2005-08-05 2007-02-15 Pall Corporation Apparatus and system for displacing gas in a biological fluid processing system
US8448786B2 (en) 2009-06-30 2013-05-28 Medline Industries, Inc. Catheter tray, packaging system, instruction insert, and associated methods
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
US20120010596A1 (en) 2010-07-06 2012-01-12 Kimberly Ann Siems Devices and Methods for Processing a Biomaterial in a Closed System
CA2826969C (en) 2010-11-29 2019-02-19 New York Blood Center, Inc. Method of blood pooling and storage
EP2892334A1 (en) 2012-09-06 2015-07-15 Biomet Biologics, LLC Methods for producing rejuvenated red blood cells
US9066909B2 (en) 2012-09-06 2015-06-30 Biomet Biologics, Llc Methods for producing and using rejuvenated red blood cells
US9102918B2 (en) 2013-01-31 2015-08-11 Biomet Biologics, Llc Methods for rejuvenating red blood cells
US9103842B2 (en) 2013-01-31 2015-08-11 Biomet Biologics, Llc Methods for rejuvenating red blood cells
US9011408B2 (en) 2013-01-31 2015-04-21 Biomet Biologics, Llc Functionally-closed, sterile blood processing solution system and method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02152923A (ja) * 1988-09-27 1990-06-12 Res Dev Corp Of Japan 体外血液循環装置に使用する血液添加組成物
JP2005535279A (ja) * 2001-11-16 2005-11-24 ホリンガー・ディジタル・インコーポレイテッド 栄養サプリメンテーションによる冷蔵赤血球の有効貯蔵期間を延長するための方法
US20050233302A1 (en) * 2004-02-18 2005-10-20 Hess John R Compositions and methods for the storage of red blood cells
WO2011103179A1 (en) * 2010-02-16 2011-08-25 Viacell, Llc Arginine-containing compositions and methods for treating red blood cells

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
TRANSFUSION, vol. 40, no. 11, JPN5016001931, November 2000 (2000-11-01), US, pages 1341 - 1345, ISSN: 0003846426 *
TRANSFUSION, vol. 48, no. 10, JPN5016001934, October 2008 (2008-10-01), pages 2096 - 2105, ISSN: 0003846428 *
TRANSFUSION, vol. 50, no. 11, JPN5016001933, November 2010 (2010-11-01), pages 2386 - 2392, ISSN: 0003846427 *
TRANSFUSION, vol. 51, no. 7, JPN5016001932, July 2011 (2011-07-01), pages 1574 - 1579, ISSN: 0004016144 *
VOX SANGUINIS, vol. 91, no. 1, JPN5016001935, 2006, pages 13 - 19, ISSN: 0003846429 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9808487B2 (en) 2013-01-31 2017-11-07 Biomet Biologics, Llc Methods for rejuvenating red blood cells
US9950012B2 (en) 2013-01-31 2018-04-24 Biomet Biologics, Llc Methods for rejuvenating red blood cells
US10898520B2 (en) 2013-01-31 2021-01-26 Biomet Biologics, Llc Methods for rejuvinating red blood cells

Also Published As

Publication number Publication date
US9808487B2 (en) 2017-11-07
US9103842B2 (en) 2015-08-11
US20150366911A1 (en) 2015-12-24
WO2014120919A1 (en) 2014-08-07
US20140212397A1 (en) 2014-07-31
EP2950802A1 (en) 2015-12-09

Similar Documents

Publication Publication Date Title
US9808487B2 (en) Methods for rejuvenating red blood cells
US10898520B2 (en) Methods for rejuvinating red blood cells
Khan et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury
US9901599B2 (en) Methods for producing and using rejuvenated red blood cells
Plaza et al. Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system
AuBuchon et al. In vitro and in vivo evaluation of leukoreduced platelets stored for 7 days in CLX containers
EP1244353B1 (en) Compositions for the storage of platelets
WO2014039660A1 (en) Methods for producing rejuvenated red blood cells
Che et al. Effects of cell salvage on erythrocyte 2, 3‐disphosphoglycerate and G‐6‐PD levels and phosphatidylserine expression
JP2022507537A (ja) 炎症を有する患者における有害事象を管理するための方法
Skogby et al. Induced cell trauma during in vitro perfusion: a comparison between two different perfusion systems
Rathbun et al. Posttransfusion survival of red cells frozen for 8 weeks after 42‐day liquid storage in AS‐3
Myers et al. A multicenter investigation into the occurrence of high-pressure excursions
US20040229205A1 (en) Compositions for the storage of platelets
Lehmann et al. Prospective comparative quality control study of a novel gravity-driven hollow-fiber whole blood separation system for the production of canine blood products
RU2452519C1 (ru) Способ компенсации глобулярного объема крови и иммуномодулирующего воздействия при трансплантации
US10253295B2 (en) Methods for producing rejuvenated red blood cells
Marabi Evaluation Of Cellular Changes, Biochemical Changes And Bacterial Contamination In Blood Stored For Transfusion At Bungoma County Referral Hospital
Kumar et al. Therapeutic Efficacy of Whole Blood Therapy in Anaemic Dogs: A Detailed Study
Arain et al. A comprehensive review of blood transfusion in small animal surgery.
RU2329054C1 (ru) Способ насыщения форменных элементов крови антибиотиками
Heldayana et al. Apheresis and hematology: How to collect the right cells
Campbell Microwave Blood Thawing: Biochemical Analysis of Small Samples of Thawed Red Blood Cells.
Cital et al. Primate Transfusion Medicine
FAYED et al. The impact of hemodialysis session on red cells antioxi-dant enzymes (Glutathione Peroxidase and Reductase) in end stage renal disease patients undergoing maintenance hemodialysis: Controlled trial

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171024

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180124

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180731

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181031

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181116

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190416